Transcatheter edge-to-edge repair in anatomically complex degenerative mitral regurgitation: 3-year outcomes from a real-world registry
Clinical Research in Cardiology · 2025-07 · 114 (7) · 904-914
DOI: 10.1007/s00392-025-02644-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 14.04.2025. Verfasst von Nicoleta Nita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Medical Center, 89081, Ulm, Germany. nicoleta.nita@uniklinik-ulm.de. Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Valve Prosthesis Implantation, Mitral Valve, Mitral Valve Insufficiency. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Ulm.
Abstract (Originalsprache)
Background
Recent developments in transcatheter mitral valve repair (M-TEER) have expanded the indication for the procedure beyond conventional criteria to include patients with anatomically complex degenerative mitral regurgitation (DMR), but long-term outcomes are not well known.
Aims
To investigate outcomes by specific anatomical criteria in patients with severe DMR and complex valve anatomy enrolled in the prospective MitraUlm registry.
Methods
Clinical and echocardiographic 3-year outcomes of 304 patients with DMR and complex mitral valve anatomy, defined according to the CLASP IID registry criteria, were investigated. Outcomes were analysed separately for specific anatomical complexities.
Results
33.5% of patients had ≥ independent significant jets, 12% multisegmental prolapse, 12.3% mitral valve orifice area < 4 cm 2 , 10.9% commissural lesions with wide/multiple jets, and 10.1% large flail. Mitral regurgitation (MR) reduction ≤ 2 was achieved in 93.8% of patients at discharge and in 85.9% at 3-year follow-up. Patients with multisegmental prolapse and commissural lesions with multiple/wide jets had the lowest MR reduction at discharge. Compared to patients treated with MitraClip Generation 1–3, patients treated with MitraClip Generation 4 had significantly better post-procedural MR reduction (MR ≤ 1 in 74.3% vs 50.7%, P < 0.001) and higher 3-year survival rates (80.2% vs 61.6%, Log Rank P = 0.002 ) . Postprocedural MR reduction to MR ≤ 1 was the strongest independent predictor of 3-year survival, whereas the presence of at least two anatomical complexities and elevated post-procedural left atrial pressure predicted 3-year all-cause mortality.
Conclusions
In patients with anatomically complex DMR, advances in procedural techniques for M-TEER have allowed successful treatment with sustained MR reduction and improved long-term survival. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine II, University Medical Center, 89081, Ulm, Germany. nicoleta.nita@uniklinik-ulm.de.
- Department of Internal Medicine II, University Medical Center, 89081, Ulm, Germany.
Förderung
- Universitätsklinikum Ulm
Zitieren
APA
Nita, N., Paukovitsch, M., Felbel, D., Gröger, M., Buckert, D., Keßler, M., & Rottbauer, W. (2025). Transcatheter edge-to-edge repair in anatomically complex degenerative mitral regurgitation: 3-year outcomes from a real-world registry. Clinical Research in Cardiology, 114(7), 904-914. https://doi.org/10.1007/s00392-025-02644-1
Vancouver
Nita N, Paukovitsch M, Felbel D, Gröger M, Buckert D, Keßler M, et al. Transcatheter edge-to-edge repair in anatomically complex degenerative mitral regurgitation: 3-year outcomes from a real-world registry. Clinical Research in Cardiology. 2025;114(7):904-914. doi:10.1007/s00392-025-02644-1
BibTeX
@article{Nita2025,
author = {Nita, Nicoleta and Paukovitsch, Michael and Felbel, Dominik and Gröger, Matthias and Buckert, Dominik and Keßler, Mirjam and Rottbauer, Wolfgang},
title = {Transcatheter edge-to-edge repair in anatomically complex degenerative mitral regurgitation: 3-year outcomes from a real-world registry},
journal = {Clinical Research in Cardiology},
year = {2025},
volume = {114},
number = {7},
pages = {904--914},
doi = {10.1007/s00392-025-02644-1}
}
EUVIMED